Sustained protective effects of 7-monohydroxyethylrutoside in an in vivo model of cardiac ischemia–reperfusion

This publication has 23 references indexed in Scilit:

• The new cardioprotector Monohydroxyethylrutoside protects against doxorubicin-induced inflammatory effects in vitro
  British Journal of Cancer, 2003
• The neutrophil as a mediator of myocardial ischemia-reperfusion injury: time to move on
  Basic Research in Cardiology, 2002
• The inflammatory response in myocardial infarction
  Cardiovascular Research, 2002
• Status of myocardial antioxidants in ischemia–reperfusion injury
  Cardiovascular Research, 2000
• Short-term and long-term blood pressure and heart rate variability in the mouse
  American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2000
• The role of neutrophils in myocardial ischemia–reperfusion injury
  Cardiovascular Research, 1999
• The Effect of CY1503, a Sialyl LewisxAnalog Blocker of the Selectin Adhesion Molecules, on Infarct Size and “No-Reflow” in the Rabbit Model of Acute Myocardial Infarction/Reperfusion
  Journal of Molecular and Cellular Cardiology, 1997
• An anti-CD18 antibody limits infarct size and preserves left ventricular function in dogs with ischemia and 48-hour reperfusion
  Journal of the American College of Cardiology, 1996
• Direct evidence that oxygen-derived free radicals contribute to postischemic myocardial dysfunction in the intact dog.
  Proceedings of the National Academy of Sciences, 1989
• Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase.
  Circulation Research, 1984